Home > English > Afghanistan News > Analysis: HIV generics under threat from tighter patenting rules

Analysis: HIV generics under threat from tighter patenting rules

Wednesday 29 September 2010

Reading time: (Number of words: )

VIENNA Monday, August 02, 2010 (IRIN) - Most of the estimated 5.2 million people worldwide on antiretroviral (ARV) treatment are taking generic versions manufactured primarily in India, but tighter global intellectual property rights and trade rules could shut down "the pharmacy of the developing world".


View online : http://www.irinnews.org/report...

loading...
loading...

Any message or comments?

pre-moderation

This forum is moderated before publication: your contribution will only appear after being validated by an administrator.

Who are you?
Log in
Your post

To create paragraphs, just leave blank lines.

Search in Kabul Press